Skip to main content
Dai Chihara, MD, Oncology, Houston, TX

DaiChiharaMD,PhD

Oncology Houston, TX

Hematologic Oncology

Fellow

Dr. Chihara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chihara's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Unit 429
    Houston, TX 77030
    Phone+1 713-792-2121

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2018 - 2020
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineResidency, Internal Medicine, 2016 - 2018
  • Kobe Univ- Fac Med
    Kobe Univ- Fac MedClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2022 - 2025
  • GA State Medical License
    GA State Medical License 2022 - 2025
  • MS State Medical License
    MS State Medical License 2022 - 2025
  • OK State Medical License
    OK State Medical License 2022 - 2025
  • TX State Medical License
    TX State Medical License 2020 - 2025
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation
    Dai Chihara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019